Oppenheimer Asset Management Inc. Cuts Stake in HCA Healthcare, Inc. $HCA

Oppenheimer Asset Management Inc. cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 3.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,154 shares of the company’s stock after selling 160 shares during the period. Oppenheimer Asset Management Inc.’s holdings in HCA Healthcare were worth $1,591,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of HCA. Interchange Capital Partners LLC boosted its stake in shares of HCA Healthcare by 6.0% during the second quarter. Interchange Capital Partners LLC now owns 3,784 shares of the company’s stock valued at $1,450,000 after purchasing an additional 213 shares during the period. Brighton Jones LLC grew its holdings in HCA Healthcare by 5.1% in the 2nd quarter. Brighton Jones LLC now owns 3,636 shares of the company’s stock worth $1,393,000 after acquiring an additional 178 shares during the last quarter. Focus Partners Advisor Solutions LLC raised its stake in shares of HCA Healthcare by 8.2% during the second quarter. Focus Partners Advisor Solutions LLC now owns 1,525 shares of the company’s stock valued at $584,000 after acquiring an additional 116 shares during the last quarter. Sage Mountain Advisors LLC grew its stake in shares of HCA Healthcare by 25.3% in the second quarter. Sage Mountain Advisors LLC now owns 1,240 shares of the company’s stock worth $475,000 after purchasing an additional 250 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its position in HCA Healthcare by 1.0% during the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 433,141 shares of the company’s stock valued at $165,936,000 after purchasing an additional 4,421 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. upped their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of HCA Healthcare in a research note on Wednesday, October 8th. Morgan Stanley set a $425.00 price target on shares of HCA Healthcare in a research note on Monday. Stephens upped their target price on HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday. Finally, Cowen restated a “buy” rating on shares of HCA Healthcare in a research report on Monday. Fourteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $473.53.

HCA Healthcare Trading Down 0.4%

HCA Healthcare stock opened at $466.44 on Friday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $478.19. The business’s fifty day simple moving average is $420.00 and its two-hundred day simple moving average is $385.66. The company has a market capitalization of $109.14 billion, a price-to-earnings ratio of 18.03, a price-to-earnings-growth ratio of 1.38 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is presently 11.13%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.